首页 > 最新文献

Biomedical Chromatography最新文献

英文 中文
A selective, sensitive and fast LC–MS/MS method for cabotegravir quantification in rat plasma and pharmacokinetic investigations 用于大鼠血浆中卡博特拉韦定量和药代动力学研究的选择性、灵敏和快速的 LC-MS/MS 方法
IF 1.8 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-09-09 DOI: 10.1002/bmc.6009
Bandaru Venkata Ramarao, Anand Solomon Kamalakaran

This study presents a novel liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for quantifying cabotegravir (CAB) in rat plasma. A novel, sensitive, and rapid LC-MS/MS method has been developed and validated. Furthermore, protein precipitation technique allowed us to lowered the limit of quantification (LOQ) to nanogram levels, allowing detection of smaller CAB amounts in plasma samples. A review of scientific literature reveals that this method is superior than published methods in terms of runtime, sensitivity, wide linearity, and cost, using LC–MS/MS to quantify CAB in biological samples. CAB reached its maximum concentration (Cmax) of 78.401 μg/mL in rat plasma at 1.50 h (Tmax). Linearity was evaluated across 0.05–1000 μg/mL for CAB using five calibration curves with at least nine standards each with r2 > 0.9997. The intra- and inter-day precision and accuracy results were below 15% and acceptable as per Food and Drug Administration (FDA) guidelines. Stability of compounds were established in a battery of stability studies, that is, benchtop, autosampler, and long-term storage stability as well as freeze thaw cycles. The validated method can be used as a routine method to support pharmacokinetic studies.

本研究介绍了一种新型液相色谱-串联质谱(LC-MS/MS)方法,用于定量检测大鼠血浆中的卡博特拉韦(CAB)。该方法是一种新型、灵敏、快速的液相色谱-串联质谱(LC-MS/MS)分析方法。此外,蛋白质沉淀技术使我们能够将定量限(LOQ)降低到纳克级,从而能够检测血浆样品中较小的卡博特拉韦含量。查阅科学文献后发现,使用 LC-MS/MS 方法定量检测生物样本中的 CAB,在运行时间、灵敏度、宽线性度和成本等方面均优于已发表的方法。CAB 在大鼠血浆中的最大浓度(Cmax)为 78.401 μg/mL,时间为 1.50 h(Tmax)。使用五条校准曲线评估了 CAB 在 0.05-1000 μg/mL 范围内的线性关系,每条曲线至少有九种标准品,r2 > 0.9997。日内和日间精密度和准确度结果均低于 15%,符合美国食品药品管理局(FDA)的规定。通过一系列稳定性研究,即台式、自动进样器、长期储存稳定性和冻融循环,确定了化合物的稳定性。经过验证的方法可用作支持药代动力学研究的常规方法。
{"title":"A selective, sensitive and fast LC–MS/MS method for cabotegravir quantification in rat plasma and pharmacokinetic investigations","authors":"Bandaru Venkata Ramarao,&nbsp;Anand Solomon Kamalakaran","doi":"10.1002/bmc.6009","DOIUrl":"10.1002/bmc.6009","url":null,"abstract":"<p>This study presents a novel liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for quantifying cabotegravir (CAB) in rat plasma. A novel, sensitive, and rapid LC-MS/MS method has been developed and validated. Furthermore, protein precipitation technique allowed us to lowered the limit of quantification (LOQ) to nanogram levels, allowing detection of smaller CAB amounts in plasma samples. A review of scientific literature reveals that this method is superior than published methods in terms of runtime, sensitivity, wide linearity, and cost, using LC–MS/MS to quantify CAB in biological samples. CAB reached its maximum concentration (Cmax) of 78.401 μg/mL in rat plasma at 1.50 h (Tmax). Linearity was evaluated across 0.05–1000 μg/mL for CAB using five calibration curves with at least nine standards each with <i>r</i><sup>2</sup> &gt; 0.9997. The intra- and inter-day precision and accuracy results were below 15% and acceptable as per Food and Drug Administration (FDA) guidelines. Stability of compounds were established in a battery of stability studies, that is, benchtop, autosampler, and long-term storage stability as well as freeze thaw cycles. The validated method can be used as a routine method to support pharmacokinetic studies.</p>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"38 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142207054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LC-ESI-MS/MS method validation for simultaneous quantification of FDA-approved anticancer agents futibatinib and binimetinib in rat plasma: Insights from preclinical pharmacokinetics LC-ESI-MS/MS 方法在大鼠血浆中同时定量 FDA 批准的抗癌药物富替巴替尼和宾美替尼的验证:临床前药代动力学的启示。
IF 1.8 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-09-05 DOI: 10.1002/bmc.6005
Shailesh D. Dadge, Shubhi Yadav, Shivam Rathaur, Jiaur R. Gayen

This study investigates the combination of FGFR inhibitor futibatinib (FTB) and MEK inhibitor binimetinib (BTB) for KRASmt NSCLC therapy. An analytical method was developed and validated for measuring FTB and BTB concentrations in rat plasma, adhering to USFDA guidelines. Using liquid–liquid extraction on 45-μL plasma samples, a 6.5-min run time was achieved. The linear calibration curve ranged from 2 to 100 ng/mL. Intra-day and inter-day accuracy ranged between 92.06% and 100.08%. Four blank injections post high-concentration samples resolved significant carryover. Extraction recoveries averaged 92.06% to 102.37% across concentrations. No significant endogenous interference was detected in blank plasma. The LLOQ for both drugs was 2.0 ng/mL. Selectivity, matrix effects, stability, and dilution integrity met the acceptance criteria. The method assessed FTB and BTB interaction potential in combination therapy at 5 mg/kg. The findings provide essential pharmacokinetics insights for future clinical trials.

本研究探讨了FGFR抑制剂福替替尼(FTB)和MEK抑制剂比尼替尼(BTB)联合治疗KRASmt NSCLC的方法。根据美国食品药品管理局(USFDA)的指导原则,开发并验证了测定大鼠血浆中FTB和BTB浓度的分析方法。对45μL血浆样品进行液液萃取,运行时间为6.5分钟。线性校准曲线范围为 2 至 100 ng/mL。日内和日间准确度为 92.06% 至 100.08%。高浓度样品后的四次空白进样解决了明显的携带问题。不同浓度的提取回收率平均为 92.06% 至 102.37%。空白血浆中未检测到明显的内源性干扰。两种药物的 LLOQ 均为 2.0 纳克/毫升。选择性、基质效应、稳定性和稀释完整性均符合验收标准。该方法评估了 FTB 和 BTB 在 5 mg/kg 联合治疗中的相互作用潜力。这些发现为未来的临床试验提供了重要的药代动力学启示。
{"title":"LC-ESI-MS/MS method validation for simultaneous quantification of FDA-approved anticancer agents futibatinib and binimetinib in rat plasma: Insights from preclinical pharmacokinetics","authors":"Shailesh D. Dadge,&nbsp;Shubhi Yadav,&nbsp;Shivam Rathaur,&nbsp;Jiaur R. Gayen","doi":"10.1002/bmc.6005","DOIUrl":"10.1002/bmc.6005","url":null,"abstract":"<p>This study investigates the combination of FGFR inhibitor futibatinib (FTB) and MEK inhibitor binimetinib (BTB) for KRASmt NSCLC therapy. An analytical method was developed and validated for measuring FTB and BTB concentrations in rat plasma, adhering to USFDA guidelines. Using liquid–liquid extraction on 45-μL plasma samples, a 6.5-min run time was achieved. The linear calibration curve ranged from 2 to 100 ng/mL. Intra-day and inter-day accuracy ranged between 92.06% and 100.08%. Four blank injections post high-concentration samples resolved significant carryover. Extraction recoveries averaged 92.06% to 102.37% across concentrations. No significant endogenous interference was detected in blank plasma. The LLOQ for both drugs was 2.0 ng/mL. Selectivity, matrix effects, stability, and dilution integrity met the acceptance criteria. The method assessed FTB and BTB interaction potential in combination therapy at 5 mg/kg. The findings provide essential pharmacokinetics insights for future clinical trials.</p>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"38 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enantiomeric separation of flavanone on Chiralpak® IA column and determination of the chiral mechanism 用 Chiralpak® IA 色谱柱分离黄烷酮对映体并确定其手性机理。
IF 1.8 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-09-05 DOI: 10.1002/bmc.6004
Imran Ali, Fatima Zohra Mimouni, Nasser Belboukhari, Khaled Sekkoum, Marcello Locatelli, Ersin Demir, Kareem Yusuf

Thirteen flavanone racemates were successfully separated using a Chiralpak® IA column and isopropanol-hexane (50:50, v/v). The mobile phase flow rate and detection wavelength were 0.5 mL/min and 254 nm. The retention times values ranged from 5.50 and 56.45 min. The values of the retention, separation, and resolution factors ranged from 0.63 to 21.67, 1.12 to 2.45, and 0.13 to 11.94. The docking binding energies ranged from −6.2 to −8.2 kcal/mol, showing enthalpy-determined host-guest complex formation. The molecular docking results and the experimental data were agreed well. The results showed that S-enantiomers had stronger bindings with chiral selectors compared to R-enantiomers. Consequently, the R-enantiomers eluted first followed by S-enantiomers. The reported method is highly useful to determine the enantiomeric composition of the reported flavanone in any sample.

使用 Chiralpak® IA 色谱柱和异丙醇-正己烷(50:50, v/v)成功分离了 13 种黄烷酮外消旋体。流动相流速为 0.5 mL/min,检测波长为 254 nm。保留时间范围为 5.50 至 56.45 分钟。保留因子、分离因子和分辨率因子分别为 0.63 至 21.67、1.12 至 2.45 和 0.13 至 11.94。对接结合能为 -6.2 至 -8.2 kcal/mol,显示了焓决定的主客复合物形成。分子对接结果与实验数据吻合良好。结果表明,与 R-对映体相比,S-对映体与手性选择子的结合力更强。因此,R-对映体首先洗脱,然后是 S-对映体。所报告的方法对于确定任何样品中黄酮的对映体组成非常有用。
{"title":"Enantiomeric separation of flavanone on Chiralpak® IA column and determination of the chiral mechanism","authors":"Imran Ali,&nbsp;Fatima Zohra Mimouni,&nbsp;Nasser Belboukhari,&nbsp;Khaled Sekkoum,&nbsp;Marcello Locatelli,&nbsp;Ersin Demir,&nbsp;Kareem Yusuf","doi":"10.1002/bmc.6004","DOIUrl":"10.1002/bmc.6004","url":null,"abstract":"<p>Thirteen flavanone racemates were successfully separated using a Chiralpak® IA column and isopropanol-hexane (50:50, v/v). The mobile phase flow rate and detection wavelength were 0.5 mL/min and 254 nm. The retention times values ranged from 5.50 and 56.45 min. The values of the retention, separation, and resolution factors ranged from 0.63 to 21.67, 1.12 to 2.45, and 0.13 to 11.94. The docking binding energies ranged from −6.2 to −8.2 kcal/mol, showing enthalpy-determined host-guest complex formation. The molecular docking results and the experimental data were agreed well. The results showed that <i>S</i>-enantiomers had stronger bindings with chiral selectors compared to <i>R</i>-enantiomers. Consequently, the <i>R</i>-enantiomers eluted first followed by <i>S</i>-enantiomers. The reported method is highly useful to determine the enantiomeric composition of the reported flavanone in any sample.</p>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"38 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development, evaluation of critical method variables and stability assessment using a Box–Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone 采用方框-贝肯设计法测定中枢作用肌松药氯唑沙宗药物剂型中的有机杂质,并对关键方法变量进行开发、评估和稳定性评价。
IF 1.8 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-09-04 DOI: 10.1002/bmc.6001
Santhosh Kumar Ettaboina, Satyasree Nannapaneni, Nagalakshmi Jeedimalla, Thirupathi Dongala, Siva Krishna Muchakayala, Naresh Kumar Katari

This study validates a stability-indicating LC method for detecting organic impurities in the chlorzoxazone dosage form. Using a Waters X-Select R HSS T3 analytical column, mobile phase of it was made by mixing of water, methanol, and glacial acetic acid in the ratio of 700:300:10 (v/v/v). The drug product and drug substance were subjected to the stress conditions such as acid, base, oxidation, heat, and photolysis as per the recommendations of the International Conference on Harmonization (Q2) methodology. The study revealed the susceptibility of 4-chloro-2-aminophenol to alkaline environments, emphasizing peak homogeneity and stability. The method verification, per ICH guidelines and USP<1225>, established precision, specificity, linearity, accuracy, and robustness for quality control. The mean impurity recovery ranged from 95.5% to 105.2%, the correlation coefficient (r) was greater than 1.000, and the RSD values (n = 6) ranged from 0.6% to 5.1% across the LOQ–150% ranges. Full-factorial design tested final method conditions, evaluating multiple parameters concurrently. Graphical optimization within the design space defined strong method requirements, ensuring consistent and reliable outcomes. The study develops and validates chlorzoxazone stability-indicating methods, employing advanced statistical approaches like design of experiments and factorial design, with resilient conditions established through graphical optimization of the design space.

本研究验证了一种检测氯唑沙宗剂型中有机杂质的稳定性指示液相色谱法。采用Waters X-Select R HSS T3分析柱,以水、甲醇和冰乙酸按700:300:10 (v/v/v) 的比例混合配制成流动相。按照国际协调会议(Q2)方法的建议,将药物产品和药物物质置于酸、碱、氧化、热和光解等应力条件下。研究表明,4-氯-2-氨基苯酚易受碱性环境的影响,强调了峰值的均匀性和稳定性。根据 ICH 指南和 USP,方法验证确定了质量控制的精确性、特异性、线性、准确性和稳健性。平均杂质回收率为 95.5% 至 105.2%,相关系数 (r) 大于 1.000,RSD 值(n = 6)在 LOQ-150% 范围内为 0.6% 至 5.1%。全因子设计测试了最终方法条件,同时评估了多个参数。设计空间内的图形优化确定了强有力的方法要求,确保了结果的一致性和可靠性。该研究开发并验证了氯唑沙宗稳定性指示方法,采用了先进的统计方法,如实验设计和因子设计,并通过设计空间的图形优化确定了弹性条件。
{"title":"Development, evaluation of critical method variables and stability assessment using a Box–Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone","authors":"Santhosh Kumar Ettaboina,&nbsp;Satyasree Nannapaneni,&nbsp;Nagalakshmi Jeedimalla,&nbsp;Thirupathi Dongala,&nbsp;Siva Krishna Muchakayala,&nbsp;Naresh Kumar Katari","doi":"10.1002/bmc.6001","DOIUrl":"10.1002/bmc.6001","url":null,"abstract":"<p>This study validates a stability-indicating LC method for detecting organic impurities in the chlorzoxazone dosage form. Using a Waters X-Select R HSS T3 analytical column, mobile phase of it was made by mixing of water, methanol, and glacial acetic acid in the ratio of 700:300:10 (v/v/v). The drug product and drug substance were subjected to the stress conditions such as acid, base, oxidation, heat, and photolysis as per the recommendations of the International Conference on Harmonization (Q2) methodology. The study revealed the susceptibility of 4-chloro-2-aminophenol to alkaline environments, emphasizing peak homogeneity and stability. The method verification, per ICH guidelines and USP&lt;1225&gt;, established precision, specificity, linearity, accuracy, and robustness for quality control. The mean impurity recovery ranged from 95.5% to 105.2%, the correlation coefficient (<i>r</i>) was greater than 1.000, and the RSD values (<i>n</i> = 6) ranged from 0.6% to 5.1% across the LOQ–150% ranges. Full-factorial design tested final method conditions, evaluating multiple parameters concurrently. Graphical optimization within the design space defined strong method requirements, ensuring consistent and reliable outcomes. The study develops and validates chlorzoxazone stability-indicating methods, employing advanced statistical approaches like design of experiments and factorial design, with resilient conditions established through graphical optimization of the design space.</p>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"38 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bmc.6001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142131728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analytical quality by design-based stability-indicating high performance liquid chromatography method for the estimation of evogliptin tartrate in bulk and tablet dosage form 基于设计的稳定性指示高效液相色谱法估算酒石酸依维列汀散剂和片剂的分析质量。
IF 1.8 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-09-03 DOI: 10.1002/bmc.5994
Shruti Srivastava, Suneela Dhaneshwar, Neha Kawathekar

The present study utilized Analytical Quality by Design (AQbD) approach to develop a stability-indicating high-performance liquid chromatography (HPLC) method for estimating evogliptin tartrate using design expert software. The key parameters were methodically optimized, contours were plotted, and stability was evaluated using various forced degradation conditions. Using an Agilent HPLC system with a photo diode array (PDA) detector along with Fortis C18 column (250 × 4.6 mm, 5 μm) effectively separated the drug from its degradants. The mobile phase used was methanol: water (pH adjusted to 3.0, 76:24; v/v) at 0.8 mL/min flow rate. Evogliptin was eluted at 2.98 min, at a detection wavelength of 267 nm. The proposed method was found to be specific, precise, linear and robust. The drug was sensitive to acidic, basic, oxidative, thermal, and photodegradation resolving six degradation products. Thus, the developed AQbD-based stability-indicating HPLC method is applicable in analyzing evogliptin in bulk, tablet dosage form and stability samples.

本研究采用设计质量分析法(AQbD),利用设计专家软件开发了一种估算酒石酸依维列汀稳定性的高效液相色谱法(HPLC)。该方法对关键参数进行了优化,绘制了等值线,并利用各种强制降解条件对稳定性进行了评估。安捷伦高效液相色谱仪配有光电二极管阵列(PDA)检测器和 Fortis C18 色谱柱(250 × 4.6 mm,5 μm),可有效分离药物及其降解物。流动相为甲醇:水(pH 值调至 3.0,76:24;v/v),流速为 0.8 mL/min。依维列汀的洗脱时间为 2.98 分钟,检测波长为 267 nm。该方法特异、准确、线性、稳健。该药物对酸性、碱性、氧化性、热降解和光降解敏感,可分离出六种降解产物。因此,所开发的基于AQbD的稳定性指示高效液相色谱法适用于分析散装、片剂和稳定性样品中的依维列汀。
{"title":"Analytical quality by design-based stability-indicating high performance liquid chromatography method for the estimation of evogliptin tartrate in bulk and tablet dosage form","authors":"Shruti Srivastava,&nbsp;Suneela Dhaneshwar,&nbsp;Neha Kawathekar","doi":"10.1002/bmc.5994","DOIUrl":"10.1002/bmc.5994","url":null,"abstract":"<p>The present study utilized Analytical Quality by Design (AQbD) approach to develop a stability-indicating high-performance liquid chromatography (HPLC) method for estimating evogliptin tartrate using design expert software. The key parameters were methodically optimized, contours were plotted, and stability was evaluated using various forced degradation conditions. Using an Agilent HPLC system with a photo diode array (PDA) detector along with Fortis C18 column (250 × 4.6 mm, 5 μm) effectively separated the drug from its degradants. The mobile phase used was methanol: water (pH adjusted to 3.0, 76:24; <i>v/v</i>) at 0.8 mL/min flow rate. Evogliptin was eluted at 2.98 min, at a detection wavelength of 267 nm. The proposed method was found to be specific, precise, linear and robust. The drug was sensitive to acidic, basic, oxidative, thermal, and photodegradation resolving six degradation products. Thus, the developed AQbD-based stability-indicating HPLC method is applicable in analyzing evogliptin in bulk, tablet dosage form and stability samples.</p>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"38 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142124709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Excretion characteristics of main compounds of Yigong San in urine, feces, and bile of rats 益宫散主要化合物在大鼠尿液、粪便和胆汁中的排泄特征
IF 1.8 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-09-03 DOI: 10.1002/bmc.5997
Jiayue Tao, Hanyi Li, Mingxuan Jin, Wenchao Shen, Siqi Liu, Dan Li, Jincai Hou, Rufeng Wang

Yigong San (YGS) is a traditional Chinese medicine formula used for pediatric anorexia, chronic atrophic gastritis, and irritable bowel syndrome. In this study, the excretion of eight main compounds, including liquiritin; isoliquiritin; hesperidin; ginsenosides Rb1, Re, and Rg1; and atractylenolides I and II, in rat urine, feces, and bile, was investigated by ultra-high performance liquid chromatography–tandem mass spectrometry. The results showed that the cumulative excretion rates of the compounds in rat urine, feces, and bile were 0.018–1.15%, 0.024–19.89%, and 0.0025–0.72%, respectively. Among the eight compounds detected, liquiritin was the richest in urine, and ginsenosides Re and Rg1 and atractylenolide I were mainly found in feces and bile. In summary, the main components of YGS are excreted via multiple approaches. Liquiritin is mainly through urine, whereas isoliquiritin; hesperidin; ginsenosides Rb1, Re, and Rg1; and atractylenolides I and II are mainly through feces. The excretion of these compounds in bile is usually positively correlated with that in feces. This study lays a foundation for further pharmacological research and application of YGS.

益胃散(YGS)是一种用于治疗小儿厌食症、慢性萎缩性胃炎和肠易激综合征的传统中药配方。本研究采用超高效液相色谱-串联质谱法研究了大鼠尿液、粪便和胆汁中 8 种主要化合物的排泄情况,包括枸杞子苷、异枸杞子苷、橙皮甙、人参皂苷 Rb1、Re 和 Rg1 以及白术内酯 I 和 II。结果表明,这些化合物在大鼠尿液、粪便和胆汁中的累积排泄率分别为 0.018-1.15%、0.024-19.89% 和 0.0025-0.72%。在检测到的 8 种化合物中,尿液中的含量最高,人参皂苷 Re 和 Rg1 以及苍术内酯 I 主要存在于粪便和胆汁中。总之,YGS 的主要成分通过多种途径排出体外。丽曲亭主要通过尿液排出,而异丽曲亭、橙皮甙、人参皂苷 Rb1、Re 和 Rg1 以及白术内酯 I 和 II 则主要通过粪便排出。这些化合物在胆汁中的排泄量通常与在粪便中的排泄量呈正相关。这项研究为 YGS 的进一步药理研究和应用奠定了基础。
{"title":"Excretion characteristics of main compounds of Yigong San in urine, feces, and bile of rats","authors":"Jiayue Tao,&nbsp;Hanyi Li,&nbsp;Mingxuan Jin,&nbsp;Wenchao Shen,&nbsp;Siqi Liu,&nbsp;Dan Li,&nbsp;Jincai Hou,&nbsp;Rufeng Wang","doi":"10.1002/bmc.5997","DOIUrl":"10.1002/bmc.5997","url":null,"abstract":"<p>Yigong San (YGS) is a traditional Chinese medicine formula used for pediatric anorexia, chronic atrophic gastritis, and irritable bowel syndrome. In this study, the excretion of eight main compounds, including liquiritin; isoliquiritin; hesperidin; ginsenosides Rb<sub>1</sub>, Re, and Rg<sub>1</sub>; and atractylenolides I and II, in rat urine, feces, and bile, was investigated by ultra-high performance liquid chromatography–tandem mass spectrometry. The results showed that the cumulative excretion rates of the compounds in rat urine, feces, and bile were 0.018–1.15%, 0.024–19.89%, and 0.0025–0.72%, respectively. Among the eight compounds detected, liquiritin was the richest in urine, and ginsenosides Re and Rg<sub>1</sub> and atractylenolide I were mainly found in feces and bile. In summary, the main components of YGS are excreted via multiple approaches. Liquiritin is mainly through urine, whereas isoliquiritin; hesperidin; ginsenosides Rb<sub>1</sub>, Re, and Rg<sub>1</sub>; and atractylenolides I and II are mainly through feces. The excretion of these compounds in bile is usually positively correlated with that in feces. This study lays a foundation for further pharmacological research and application of YGS.</p>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"38 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142118908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacokinetic study of iptacopan and its two acyl glucuronide metabolites in monkey plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry 利用液相色谱法结合电喷雾离子化串联质谱法研究猴子血浆中依他卡潘及其两种酰基葡萄糖醛酸代谢物的药代动力学。
IF 1.8 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-09-03 DOI: 10.1002/bmc.6002
Jingchu Li, Shanshan Liu, Chenglin Jia, Jiacheng Li, Zhihui Zhang, Jian Chen, Yongbin Cao, Chao Ma

In this study, a simple and sensitive liquid chromatography tandem mass spectrometric method was developed and validated for the determination of iptacopan and two acyl glucuronidation metabolites in monkey plasma. The plasma sample was precipitated with acetonitrile and then separated on an Acquity UPLC BEH C18 column (2.1 × 100 mm, 1.7 μm) using 0.1% formic acid and 5 mM ammonium acetate in water and acetonitrile as the mobile phase. The mass spectrometry (MS) detection was performed in positive multiple reactions monitoring (MRM) mode with precursor-to-production transitions. The developed assay was validated over the range of 1–2000 ng/mL for three analytes with correlation coefficient (r) more than 0.99. The validation parameters including accuracy, precision, carryover effect, matrix effect, recovery, and stability were all within the acceptable limits. The validated method has been applied to investigate the pharmacokinetics of iptacopan and its two acyl glucuronidation metabolites in monkey plasma. After intravenous administration, iptacopan showed low clearance (2.75 mL/min/kg) in monkey plasma. After oral administration, the bioavailability was 55.43%. The exposure (AUC0−t) of direct acyl glucuronide (AG) of iptacopan accounts for 9.73% of the iptacopan plasma exposure. The AUC0−t of AG of dealkylated metabolite of iptacopan was present at a lower level, accounting for 0.5% of the iptacopan plasma exposure.

本研究建立了一种简便灵敏的液相色谱串联质谱法,用于测定猴子血浆中的依他卡潘和两种酰基葡萄糖醛酸化代谢物。血浆样品经乙腈沉淀后,用 Acquity UPLC BEH C18 色谱柱(2.1 × 100 mm, 1.7 μm)分离,流动相为 0.1%甲酸和 5 mM 乙酸铵水溶液及乙腈。质谱(MS)检测采用正多反应监测(MRM)模式,并进行前体到生成物的转换。所开发的检测方法在 1-2000 纳克/毫升的范围内对三种分析物进行了验证,相关系数(r)大于 0.99。验证参数包括准确度、精密度、携带效应、基质效应、回收率和稳定性均在可接受范围内。应用所验证的方法研究了猴子血浆中依他卡潘及其两种酰基葡萄糖醛酸化代谢物的药代动力学。静脉注射后,猴子血浆中的依他卡潘清除率较低(2.75 mL/min/kg)。口服后,生物利用度为 55.43%。伊帕可潘的直接酰基葡萄糖醛酸(AG)暴露量(AUC0-t)占伊帕可潘血浆暴露量的 9.73%。伊帕可潘脱烷基代谢物 AG 的 AUC0-t 值较低,占伊帕可潘血浆暴露量的 0.5%。
{"title":"Pharmacokinetic study of iptacopan and its two acyl glucuronide metabolites in monkey plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry","authors":"Jingchu Li,&nbsp;Shanshan Liu,&nbsp;Chenglin Jia,&nbsp;Jiacheng Li,&nbsp;Zhihui Zhang,&nbsp;Jian Chen,&nbsp;Yongbin Cao,&nbsp;Chao Ma","doi":"10.1002/bmc.6002","DOIUrl":"10.1002/bmc.6002","url":null,"abstract":"<p>In this study, a simple and sensitive liquid chromatography tandem mass spectrometric method was developed and validated for the determination of iptacopan and two acyl glucuronidation metabolites in monkey plasma. The plasma sample was precipitated with acetonitrile and then separated on an Acquity UPLC BEH C18 column (2.1 × 100 mm, 1.7 μm) using 0.1% formic acid and 5 mM ammonium acetate in water and acetonitrile as the mobile phase. The mass spectrometry (MS) detection was performed in positive multiple reactions monitoring (MRM) mode with precursor-to-production transitions. The developed assay was validated over the range of 1–2000 ng/mL for three analytes with correlation coefficient (<i>r</i>) more than 0.99. The validation parameters including accuracy, precision, carryover effect, matrix effect, recovery, and stability were all within the acceptable limits. The validated method has been applied to investigate the pharmacokinetics of iptacopan and its two acyl glucuronidation metabolites in monkey plasma. After intravenous administration, iptacopan showed low clearance (2.75 mL/min/kg) in monkey plasma. After oral administration, the bioavailability was 55.43%. The exposure (AUC<sub>0−<i>t</i></sub>) of direct acyl glucuronide (AG) of iptacopan accounts for 9.73% of the iptacopan plasma exposure. The AUC<sub>0−<i>t</i></sub> of AG of dealkylated metabolite of iptacopan was present at a lower level, accounting for 0.5% of the iptacopan plasma exposure.</p>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"38 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142124719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating untargeted and targeted LC–MS-based metabolomics to identify the serum metabolite biomarkers for tuberculosis 整合基于 LC-MS 的非靶向和靶向代谢组学,确定结核病的血清代谢物生物标志物。
IF 1.8 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-08-28 DOI: 10.1002/bmc.5998
Yuping Sa, Shuqin Ding, Yue Zhang, Weibiao Wang, Gidion Wilson, Feng Ma, Weiman Zhang, Xueqin Ma

Given the limitations of untargeted metabolomics in precise metabolite quantification, our current research employed a novel approach by integrating untargeted and targeted metabolomics utilizing ultra-high-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (UHPLC-QTOF-MS/MS) to analyze the metabolic profile and potential biomarkers for tuberculosis (TB). A cohort of 36 TB patients and 36 healthy controls (HC) was enlisted to obtain serum samples. Multivariate pattern recognition and univariate statistical analysis were employed to screen and elucidate the differential metabolites, whereas dot plots and receiver operating characteristic (ROC) curves were established for the identification of potential biomarkers of TB. The results indicated a distinct differentiation between the two groups, identifying 99 metabolites associated with five primary metabolic pathways in relation to TB. Of these, 19 metabolites exhibited high levels of sensitivity and specificity, as evidenced by the area under curve values approaching 1. Following targeted quantitative analysis, three potential metabolites, namely, L-asparagine, L-glutamic acid, and arachidonic acid, were demonstrated excellent discriminatory ability as evidenced by the results of the ROC curve, dot plots, and random forest model. Particularly noteworthy was the enhanced diagnostic efficacy of the combination of these three metabolites compared to singular biomarkers, suggesting their potential utility as serum biomarkers for TB diagnosis.

鉴于非靶向代谢组学在精确定量代谢物方面的局限性,我们目前的研究采用了一种新方法,即利用超高效液相色谱-四极杆飞行时间串联质谱(UHPLC-QTOF-MS/MS)将非靶向和靶向代谢组学结合起来,分析结核病(TB)的代谢特征和潜在生物标记物。研究人员采集了 36 名肺结核患者和 36 名健康对照者(HC)的血清样本。采用多变量模式识别和单变量统计分析来筛选和阐明不同的代谢物,并绘制点图和接收者操作特征曲线(ROC)来识别结核病的潜在生物标记物。结果表明,两组之间存在明显的差异,共鉴定出与肺结核相关的五个主要代谢途径中的 99 个代谢物。其中,19 个代谢物表现出较高的灵敏度和特异性,曲线下面积值接近 1 即为证明。经过有针对性的定量分析,三个潜在的代谢物(L-天冬酰胺、L-谷氨酸和花生四烯酸)表现出了极佳的鉴别能力,这一点可以从 ROC 曲线、点图和随机森林模型的结果中得到证明。尤其值得注意的是,与单一生物标记物相比,这三种代谢物的组合具有更强的诊断效果,这表明它们作为血清生物标记物在结核病诊断中具有潜在的实用性。
{"title":"Integrating untargeted and targeted LC–MS-based metabolomics to identify the serum metabolite biomarkers for tuberculosis","authors":"Yuping Sa,&nbsp;Shuqin Ding,&nbsp;Yue Zhang,&nbsp;Weibiao Wang,&nbsp;Gidion Wilson,&nbsp;Feng Ma,&nbsp;Weiman Zhang,&nbsp;Xueqin Ma","doi":"10.1002/bmc.5998","DOIUrl":"10.1002/bmc.5998","url":null,"abstract":"<p>Given the limitations of untargeted metabolomics in precise metabolite quantification, our current research employed a novel approach by integrating untargeted and targeted metabolomics utilizing ultra-high-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (UHPLC-QTOF-MS/MS) to analyze the metabolic profile and potential biomarkers for tuberculosis (TB). A cohort of 36 TB patients and 36 healthy controls (HC) was enlisted to obtain serum samples. Multivariate pattern recognition and univariate statistical analysis were employed to screen and elucidate the differential metabolites, whereas dot plots and receiver operating characteristic (ROC) curves were established for the identification of potential biomarkers of TB. The results indicated a distinct differentiation between the two groups, identifying 99 metabolites associated with five primary metabolic pathways in relation to TB. Of these, 19 metabolites exhibited high levels of sensitivity and specificity, as evidenced by the area under curve values approaching 1. Following targeted quantitative analysis, three potential metabolites, namely, L-asparagine, L-glutamic acid, and arachidonic acid, were demonstrated excellent discriminatory ability as evidenced by the results of the ROC curve, dot plots, and random forest model. Particularly noteworthy was the enhanced diagnostic efficacy of the combination of these three metabolites compared to singular biomarkers, suggesting their potential utility as serum biomarkers for TB diagnosis.</p>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"38 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dissipation pattern and dietary risk assessment of chlorfenapyr and methomyl in corn under Egyptian field conditions 埃及田间条件下玉米中氟虫腈和灭多威的消散模式和膳食风险评估。
IF 1.8 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-08-27 DOI: 10.1002/bmc.5992
El-Sayed Saber, Farag Malhat, Ayman N. Saber, Sara Heikal, Mohamed Hussien

Corn is the second most widely farmed grain for human consumption. Low corn productivity due to damage caused by pests has led to using pesticides to control pest infestations. However, the uncontrolled application of pesticides on corn harms both environmental and human health. Accordingly, field experiments followed good agricultural practices to investigate the dissipation pattern and terminal residues of chlorfenapyr and methomyl in corn and compare the values with established safety limits. Gas chromatography–tandem mass spectrometer coupled with the quick, easy, cheap, effective, rugged, and safe technique was used to analyze residues of chlorfenapyr and methomyl in corn. The average recoveries varied from 94% to 105%, with relative standard deviations (RSDs) of 8%–13% for chlorfenapyr and from 99% to 111%, with RSDs of 10–16% for methomyl. Chlorfenapyr and methomyl residues degraded in corn following a first-order kinetic model, with an estimated half-life (t1/2) of 3.9 and 2.8 days, respectively, and significant degradation (91.4%–98.1.5%, respectively) after 14 days. Although the maximum residue limits of chlorfenapyr and methomyl for corn are yet to be formulated in Egypt, the long-term dietary risk for those pesticides was acceptable, with arisk quotient < 100%, according to the national assessments. These findings are required to guide the correct and safe application of these insecticides in Egypt.

玉米是人类食用的第二大粮食作物。由于虫害造成的玉米产量低下,人们开始使用杀虫剂来控制虫害。然而,在玉米上无节制地使用杀虫剂会对环境和人类健康造成危害。因此,按照良好农业规范进行了田间试验,以研究玉米中氟虫腈和灭多威的消散模式和最终残留量,并将其值与规定的安全限值进行比较。气相色谱-串联质谱仪与快速、简便、廉价、有效、坚固和安全的技术相结合,用于分析玉米中氟虫腈和灭多威的残留量。氯虫苯甲酰胺的平均回收率从 94% 到 105%不等,相对标准偏差 (RSD) 为 8%-13%;灭多威的平均回收率从 99% 到 111%不等,RSD 为 10%-16%。氯虫苯甲酰胺和灭多威残留物在玉米中的降解遵循一阶动力学模型,估计半衰期(t1/2)分别为 3.9 天和 2.8 天,14 天后降解显著(分别为 91.4%-98.1.5% )。虽然埃及尚未制定氯虫苯甲酰胺和灭多威在玉米中的最大残留限量,但这两种农药的长期膳食风险是可以接受的,其风险商数如下
{"title":"Dissipation pattern and dietary risk assessment of chlorfenapyr and methomyl in corn under Egyptian field conditions","authors":"El-Sayed Saber,&nbsp;Farag Malhat,&nbsp;Ayman N. Saber,&nbsp;Sara Heikal,&nbsp;Mohamed Hussien","doi":"10.1002/bmc.5992","DOIUrl":"10.1002/bmc.5992","url":null,"abstract":"<p>Corn is the second most widely farmed grain for human consumption. Low corn productivity due to damage caused by pests has led to using pesticides to control pest infestations. However, the uncontrolled application of pesticides on corn harms both environmental and human health. Accordingly, field experiments followed good agricultural practices to investigate the dissipation pattern and terminal residues of chlorfenapyr and methomyl in corn and compare the values with established safety limits. Gas chromatography–tandem mass spectrometer coupled with the quick, easy, cheap, effective, rugged, and safe technique was used to analyze residues of chlorfenapyr and methomyl in corn. The average recoveries varied from 94% to 105%, with relative standard deviations (RSDs) of 8%–13% for chlorfenapyr and from 99% to 111%, with RSDs of 10–16% for methomyl. Chlorfenapyr and methomyl residues degraded in corn following a first-order kinetic model, with an estimated half-life (<i>t</i><sub>1/2</sub>) of 3.9 and 2.8 days, respectively, and significant degradation (91.4%–98.1.5%, respectively) after 14 days. Although the maximum residue limits of chlorfenapyr and methomyl for corn are yet to be formulated in Egypt, the long-term dietary risk for those pesticides was acceptable, with arisk quotient &lt; 100%, according to the national assessments. These findings are required to guide the correct and safe application of these insecticides in Egypt.</p>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"38 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bmc.5992","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142071926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolomics combined with network pharmacology to investigate the pharmacodynamic components and potential mechanisms of the spermatogenic function of the Youjing granule 代谢组学与网络药理学相结合,研究尤精颗粒生精功能的药效成分和潜在机制。
IF 1.8 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-08-27 DOI: 10.1002/bmc.5967
Mingxin Guo, Yujiao Chu, Wenjiao Zhu, Miaomiao Sun, Qiang Lv, Ruijie Tang, Xuping Jiang, Jiahao Zhao, Zhian Tang, Tieliang Ma

This study aims to identify potential efficacy-related biomarkers and investigate the mechanism of Youjing granule (YG) in improving spermatogenic function in rats based on metabolomics combined with network pharmacology. We obtained YG-containing serum from Sprague–Dawley rats, compared it with control group serum and analyzed it using gas chromatography–mass spectroscopy to identify potential biomarkers and investigate the mechanism of YG in improving spermatogenic function in rats. Six important differential biomarkers, comprising putrescine, amidine, arginine, d-fructose-6-phosphate, l-proline and galactose, were identified in the YG-containing serum and then used to explore the potential mechanisms. The ultra-high-performance liquid chromatography–high-resolution mass spectrometry technology was adopted for the rapid separation, identification and analysis of chemical components of YG in blood. A total of 69 detected chromatographic peaks were revealed. The binding energy between core compounds and key proteins is low, among which dipsacoside B is the best. The outcomes suggest that YG may improve spermatogenic function in rats by facilitating the development of spermatogonial stem cells, counteracting oxidative stress and controlling cellular apoptosis. Youjing granule may also affect the energy required for sperm production or influence sperm growth and maturation.

本研究旨在基于代谢组学结合网络药理学,识别潜在的功效相关生物标志物,并研究尤精颗粒(YG)改善大鼠生精功能的机制。我们从Sprague-Dawley大鼠体内获得了含YG的血清,将其与对照组血清进行比较,并利用气相色谱-质谱联用技术对其进行分析,以确定潜在的生物标志物并研究YG改善大鼠生精功能的机制。结果发现,含YG血清中存在6种重要的差异生物标志物,包括腐胺、脒、精氨酸、d-果糖-6-磷酸、l-脯氨酸和半乳糖,并以此探索其潜在机制。采用超高效液相色谱-高分辨质谱技术对血液中的 YG 化学成分进行了快速分离、鉴定和分析。共检测到 69 个色谱峰。核心化合物与关键蛋白的结合能较低,其中以二皂苷 B 的结合能最高。研究结果表明,YG 可通过促进精原干细胞的发育、对抗氧化应激和控制细胞凋亡来改善大鼠的生精功能。尤精颗粒还可能影响精子生成所需的能量,或影响精子的生长和成熟。
{"title":"Metabolomics combined with network pharmacology to investigate the pharmacodynamic components and potential mechanisms of the spermatogenic function of the Youjing granule","authors":"Mingxin Guo,&nbsp;Yujiao Chu,&nbsp;Wenjiao Zhu,&nbsp;Miaomiao Sun,&nbsp;Qiang Lv,&nbsp;Ruijie Tang,&nbsp;Xuping Jiang,&nbsp;Jiahao Zhao,&nbsp;Zhian Tang,&nbsp;Tieliang Ma","doi":"10.1002/bmc.5967","DOIUrl":"10.1002/bmc.5967","url":null,"abstract":"<p>This study aims to identify potential efficacy-related biomarkers and investigate the mechanism of Youjing granule (YG) in improving spermatogenic function in rats based on metabolomics combined with network pharmacology. We obtained YG-containing serum from Sprague–Dawley rats, compared it with control group serum and analyzed it using gas chromatography–mass spectroscopy to identify potential biomarkers and investigate the mechanism of YG in improving spermatogenic function in rats. Six important differential biomarkers, comprising putrescine, amidine, arginine, <span>d</span>-fructose-6-phosphate, <span>l</span>-proline and galactose, were identified in the YG-containing serum and then used to explore the potential mechanisms. The ultra-high-performance liquid chromatography–high-resolution mass spectrometry technology was adopted for the rapid separation, identification and analysis of chemical components of YG in blood. A total of 69 detected chromatographic peaks were revealed. The binding energy between core compounds and key proteins is low, among which dipsacoside B is the best. The outcomes suggest that YG may improve spermatogenic function in rats by facilitating the development of spermatogonial stem cells, counteracting oxidative stress and controlling cellular apoptosis. Youjing granule may also affect the energy required for sperm production or influence sperm growth and maturation.</p>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"38 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142071928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical Chromatography
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1